Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. SpringWorks Therapeutics Inc shares valued at $839,336 were sold by Edris Badreddin on Dec 03 ’24. At $41.97 per share, Edris Badreddin sold 20,000 shares. The insider’s holdings dropped to 209,600 shares worth approximately $7.02 million following the completion of this transaction.
Also, Islam Saqib sold 49,000 shares, netting a total of over 2,027,357 in proceeds. Following the sale of shares at $41.37 each, the insider now holds 1,014,368 shares.
Before that, Islam Saqib had sold 49,000 shares from its account. In a trade valued at $1,988,033, the Chief Executive Officer traded SpringWorks Therapeutics Inc shares for $40.57 each. Upon closing the transaction, the insider’s holdings decreased to 49,000 shares, worth approximately $35.6 million.
As published in their initiating research note from Evercore ISI on November 20, 2024, SpringWorks Therapeutics Inc [SWTX] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early February. As of December 01, 2022, BofA Securities has initiated its “Buy” rating for SWTX. Earlier on January 19, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for SWTX stock.
Analyzing SWTX Stock Performance
During the last five days, there has been a drop of approximately -18.74%. Over the course of the year, SpringWorks Therapeutics Inc shares have dropped approximately -7.33%. Shares of the company reached a 52-week high of $45.65 on 01/07/25 and a 52-week low of $31.95 on 01/15/25. A 50-day SMA is recorded $37.40, while a 200-day SMA reached $38.10. Nevertheless, trading volume fell to 1.74 million shares from 2.67 million shares the previous day.
Support And Resistance Levels for SpringWorks Therapeutics Inc (SWTX)
According to the 24-hour chart, there is a support level at 32.13, which, if violated, would cause prices to drop to 30.77. In the upper region, resistance lies at 34.66. The next price resistance is at 35.84. RSI (Relative Strength Index) is 39.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.07, which suggests the price will decrease in the coming days. Percent R is at 88.86%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of SpringWorks Therapeutics Inc (SWTX)?
On October 29, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $73.
